James E. Hoyes

James E. Hoyes

Chief Executive Officer presso Alitair Pharmaceuticals, Inc.

Health Technology
Commercial Services
Consumer Non-Durables

Profilo

James E.
Hoyes
is currently the Chairman & Chief Executive Officer at Alitair Pharmaceuticals, Inc. He is also a Director at the Biotechnology Innovation Organization and a Director at the Massachusetts Biotechnology Council since 2012.
Previously, he worked as a Director at the Pharmaceutical Research & Manufacturers of America, a Principal at Elan Corp.
Plc, and a Principal at Sterling Drug, Inc. From 2013 to 2013, he served as the President & Head-US Operations at EMD Serono, Inc. He also held positions as a Principal at Sanofi-Synthelabo, Inc. and Sanofi-Aventis Ltd.
Mr. Hoyes completed his undergraduate degree at The Pennsylvania State University.

Posizioni attive di James E. Hoyes

SocietàPosizioneInizio
Director/Board Member 27/03/2012
Director/Board Member -
Chief Executive Officer 01/01/2017
Tutte le posizioni attive di James E. Hoyes

Precedenti posizioni note di James E. Hoyes

SocietàPosizioneFine
President 30/09/2013
Director/Board Member -
Sterling Drug, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
Sanofi-Synthelabo, Inc. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di James E. Hoyes

Formazione di James E. Hoyes

The Pennsylvania State University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James E. Hoyes

Relazioni

100 +

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private9

Health Technology

Commercial Services

Sterling Drug, Inc.

Consumer Non-Durables

Health Technology

Health Technology

Commercial Services

Sanofi-Synthelabo, Inc.

Health Technology

Health Technology

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. James E. Hoyes